iBio, Inc.

Nasdaq:IBIO

Pharmaceutical Preparations·NEW YORK, NY

CFO

Duran Felipe

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/10/26	→
10-Q/A	Q3 2025	9/30/25	11/17/25	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-K	FY 2025	6/30/25	9/5/25	→
10-Q	Q1 2025	3/31/25	5/2/25	→
10-Q	Q4 2024	12/31/24	2/10/25	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
2/10/26	Q3 FY2026	→
11/12/25	Q2 FY2026	→
9/5/25	Q1 FY2026	→
8/18/25	Q1 FY2026	→
5/2/25	Q4 FY2025	→
2/10/25	Q3 FY2025	→
↓

News (8-K)

65 shown

Filed	Type	Description
2/27/26	Agreement	Entry into a Material Definitive Agreement	→
1/12/26	Agreement	Entry into a Material Definitive Agreement	→
11/21/25	Vote	Submission of Matters to a Vote of Security Holders	→
11/17/25	Reg FD	Regulation FD Disclosure	→
11/4/25	Other	Other Events	→
10/30/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
3/6/26	424B5	424B5	→
2/27/26	S-3	S-3	→
2/9/26	424B3	424B3	→
1/30/26	S-3	S-3	→
10/6/25	ARS	ARS	→
8/21/25	424B5	425B5	→
↓

Filing History(861 filings)

TypeDateAccessionPeriodSize

424B5

Mar 6, 2026

0001104659-26-024795424B5

—

297.3 KB

8-K

Feb 27, 2026

0001104659-26-021654FORM 8-K

Feb 23, 2026

196.9 KB

S-3

Feb 27, 2026

0001104659-26-021610FORM S-3

—

1.6 MB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016622

—

15.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0000935836-26-000115

—

20.0 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001049

—

9.8 KB

10-Q

Feb 10, 2026

0001420720-26-00000410-Q

Dec 31, 2025

10.3 MB

8-K

Feb 10, 2026

0001420720-26-0000038-K

Feb 10, 2026

364.8 KB

EFFECT

Feb 9, 2026

9999999995-26-000488

—

1.9 KB

424B3

Feb 9, 2026

0001104659-26-012183424B3

—

313.4 KB

S-3

Jan 30, 2026

0001104659-26-008643FORM S-3

—

576.8 KB

Jan 30, 2026

0001104659-26-008266OWNERSHIP DOCUMENT

Jan 28, 2026

5.8 KB

Jan 30, 2026

0001104659-26-008265OWNERSHIP DOCUMENT

Jan 28, 2026

5.7 KB

Jan 30, 2026

0001104659-26-008262OWNERSHIP DOCUMENT

Jan 28, 2026

5.8 KB

SCHEDULE 13G/A

Jan 29, 2026

0001315863-26-000102

—

15.4 KB

SCHEDULE 13G

Jan 22, 2026

0001104659-26-005856

—

18.3 KB

Jan 22, 2026

0001104659-26-005775

—

16.3 KB

8-K

Jan 12, 2026

0001104659-26-002940FORM 8-K

Jan 8, 2026

759.7 KB

SCHEDULE 13G

Dec 19, 2025

0000935836-25-000726

—

20.1 KB

SCHEDULE 13G

Dec 17, 2025

0000935836-25-000725

—

15.5 KB

SCHEDULE 13G

Dec 16, 2025

0001231919-25-000627

—

15.0 KB

SCHEDULE 13G/A

Dec 3, 2025

0001011438-25-000590

—

9.8 KB

Nov 24, 2025

0001104659-25-115414OWNERSHIP DOCUMENT

Nov 20, 2025

5.5 KB

Nov 24, 2025

0001104659-25-115411OWNERSHIP DOCUMENT

Nov 20, 2025

5.5 KB

Nov 24, 2025

0001104659-25-115410OWNERSHIP DOCUMENT

Nov 20, 2025

5.5 KB

25 filings shown

Filed	Form	Description
10/6/25	DEF 14A	DEF 14A	→
10/10/24	DEF 14A	DEF 14A	→
10/26/23	DEF 14A	DEF 14A	→
10/16/23	PRE 14A	PRE 14A	→
12/2/22	DEFA14A	DEFA14A	→
10/26/22	DEF 14A	DEF 14A	→
↓

iBio, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(861 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/30/26	4	OWNERSHIP DOCUMENT	→
1/30/26	4	OWNERSHIP DOCUMENT	→
1/30/26	4	OWNERSHIP DOCUMENT	→
11/24/25	4	OWNERSHIP DOCUMENT	→
11/24/25	4	OWNERSHIP DOCUMENT	→
11/24/25	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/9/26	EFFECT	EFFECT	→
1/29/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/22/26	SCHEDULE 13G	SCHEDULE 13G	→
↓